food and drug administration

food and drug administration, cancer and Recall

Blood pressure drug recalled over cancer concerns. What it means for Ohioans

Over half a million bottles of prazosin hydrochloride capsules, a blood pressure medication, are being recalled over a cancer-causing chemical found in the prescription drug, according to the U.S. Fo...

Independent Journal Review · 19h

FDA: Over Half a Million Bottles of Blood Pressure Drug Recalled Over Cancer Risk Concerns

· 23h · on MSN

FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical

· 12h

FDA recalls blood pressure medication over cancer risk, impacting half a million bottles

The recall warned for potential "temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”

· 4h

FDA: Blood Pressure Medication Recall Yet Again For Cancer Concerns

KTBS · 1d

Half a million bottles of blood pressure drug recalled for high carcinogen levels

21h

US FDA warns four firms over unapproved fluoride drugs for children

Food and Drug Administration has warned four companies that it plans to take enforcement action over their sale of unapproved fluoride-based prescription drugs for children, the agency said on Friday.

India Today on MSN

First GLP-1 drug approved to protect against heart attacks, stroke

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes patients. The drug can be prescribed to reduce major adverse cardiovascular issues even in patients who have not yet experienced these events.

20hon MSN

FDA announces plans to relax rules about copycat drugs

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.

Watch live: RFK Jr., FDA chief give remarks on lowering drug prices

Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary will give remarks on the Trump administration’s push to lower drug

10hon MSN

Doctors issue warning about ‘autism drug’ endorsed by Trump administration

More parents are asking with autistic children are asking to prescribe leucovorin despite a lack of data about its benefits

FDA to Speed Biosimilar Approvals in Push to Cut Drug Costs (1)

The FDA is planning to speed approvals of highly similar copies of expensive biologic drugs, the latest effort in President Donald Trump’s aggressive agenda to lower costs for medicines in the US.

2don MSN

Federal health officials push effort to spur cheaper biotech drugs

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers.

Trump Administration Eases Approval Process for Biosimilar Drugs

The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive for drugmakers to develop biosimilar medicines, the copycat versions of off-patent biologic drugs.

The Manila Times

Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma

CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression Free Survival and Overall Survival

1don MSN

New deaths and illnesses reported in listeria outbreak tied to recalled pasta meals

Two new deaths and seven more illnesses have been reported in an expanding outbreak of listeria food poisoning tied to recalled pasta meals sold at grocery stores including Walmart and Trader Joe's in many states.